(Reuters) – Shares of Inogen Inc fell nearly 7 percent on Thursday after short seller Citron Research called the oxygen supply device maker the most expensive name in medical technology with no pipeline.
Shares of the company were trading down at $161.88.
(Reporting by Vibhuti Sharma in Bengaluru; Editing by Bernard Orr)
